ECTS Abstracts (2015) 1 OC4.5

Tracking of 25-hydroxyvitamin D status in pregnant women

Rebecca Moon1,2, Sarah Crozier1, Sian Robinson1, Hazel Inskip1, Keith Godfrey1,3, Cyrus Cooper1,4 & Nicholas Harvey1,3

1MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, Hampshire, UK; 2Paediatric Endocrinology, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK; 3NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, UK; 4NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, Oxfordshire, UK.

Background: When assessed in pregnancy studies, 25(OH)D is usually measured only once. However, it is unknown whether the ranking of an individual’s 25(OH)D is maintained across pregnancy, which crosses several seasons. We therefore assessed the tracking of 25(OH)D from early to late pregnancy in a prospective mother–offspring study, the Southampton Women’s Survey.

Methods: At 14 and 34 weeks gestation, serum 25(OH)D was measured, and diet and lifestyle questionnaires completed. We modelled seasonal variation in 25(OH)D separately for each time point using Fourier transformations, and then calculated the difference between actual 25(OH)D and the modelled value corresponding to the sampling date for each individual (denoted 25(OH)Ddev). We used Spearman’s rank correlation to test tracking of 25(OH)Ddev from 14 to 34 weeks gestation. Multivariate linear regression was used to determine factors associated with alterations in an individual’s 25(OH)Ddev ranking.

Results: 25(OH)D was available in 2060 and 2332 women at 14 and 34 weeks, respectively, with 1756 women included at both gestations. 25(OH)Ddev tracked moderately from 14 to 34 weeks (r=0.57, P<0.0001), although some women had marked changes in 25(OH)Ddev across pregnancy (median: −0.8; range: −150.1 to 129.6 nmol/l). 25(OH)D tended to fall with greater pregnancy weight gain (25(OH)Ddev β=−0.4 nmol/l per kg, P=0.02), and to rise with greater strenuous activity in late pregnancy (β=1.0 nmol/l per h per week, P=0.03). Vitamin D supplementation was the strongest influence on tracking: compared with women who never used supplements, discontinuing supplementation after 14 weeks was associated with negative change in 25(OH)dev (β=−7.2 nmol/l, P<0.001), whereas commencing (β=12.2 nmol/l, P<0.001) or continuing (β=8.0 nmol/l, P<0.001) supplementation were positively associated.

Conclusion: Stability of an individual’s gestational 25(OH)D relative to the population is modest, and affected by weight changes, activity levels and vitamin D supplementation. These findings may explain some of the observed heterogeneity in studies relating maternal vitamin D status to offspring health.

Disclosure: K Godfrey has acted as a consultant to Abbott Nutrition and Nestle Nutrition. He is part of an academic consortium that has received research funding from Abbott Nutrition, Nestec and Danone. This work was supported by the Medical Research Council, British Heart Foundation, Arthritis Research UK, National Osteoporosis Society, International Osteoporosis Foundation, Cohen Trust, NIHR Southampton Biomedical Research Centre, and NIHR Musculoskeletal Biomedical Research Unit, University of Oxford and the Dunhill Medical Trust.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts